Juvenescence completes Phase 1 trial for first-in-class PAI-1 inhibitor, moving closer to tackling key aging mechanisms and fibrotic disease.
vist.ly/4tg4z
#longevity #Biotech #DrugDevelopment #ClinicalTrials #AgingResearch #Geroprotection #TranslationalMedicine
2
0
0
0